scispace - formally typeset
I

Irving F. Hoffman

Researcher at University of North Carolina at Chapel Hill

Publications -  288
Citations -  20382

Irving F. Hoffman is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 52, co-authored 270 publications receiving 18634 citations. Previous affiliations of Irving F. Hoffman include Kamuzu Central Hospital & FHI 360.

Papers
More filters
Journal ArticleDOI

Client and Provider Perspectives on Antiretroviral Treatment Uptake and Adherence Among People Who Inject Drugs in Indonesia, Ukraine and Vietnam: HPTN 074.

TL;DR: Differences between provider and PWID perspectives suggest a gap in providers’ understanding of PWID, which will be important as countries with a significant HIV burden among PWID design and implement programs to engage HIV-infected PWID in care and treatment.
Journal ArticleDOI

Prevalence and correlates of probable depression and post-traumatic stress disorder among female sex workers in Lilongwe, Malawi.

TL;DR: Assessment of the prevalence and correlates of probable depression, post-traumatic stress disorder (PTSD), and suicidal ideation in a cohort of 200 female sex workers in Lilongwe, Malawi foundInterventions are needed to diagnose mental health disorders among FSW at great risk for HIV/STIs.
Journal ArticleDOI

Asymptomatic Plasmodium falciparum malaria prevalence among adolescents and adults in Malawi, 2015-2016.

TL;DR: A higher parasite prevalence in adults than published estimates among children is demonstrated, and urbanicity, greater wealth, higher education, and lower environmental temperatures are considered to be protective factors.
Journal ArticleDOI

Inpatient mortality rates during an era of increased access to HIV testing and ART: A prospective observational study in Lilongwe, Malawi

TL;DR: HIV related mortality remains high among medical inpatients, especially among HIV-positive patients who recently initiated ART or have not started ART yet, and among HIV the impact of HIV and ART status on mortality is unknown.